Full-Time

Associate Director Regulatory Labeling

Posted on 12/22/2023

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology

Compensation Overview

$144,000 - $180,000Annually

+ Bonus + Equity

Senior

San Diego, CA, USA

Required Skills
Marketing
Requirements
  • Bachelor degree in a scientific discipline or related field; advanced degree (e.g., PharmD) preferred.
  • 8 years of progressively responsible Regulatory Affairs experience and 6 years' experience in global labeling.
  • Significant experience in global prescription drug labeling, U.S., EU, Australia, Canada, Japan, and/or Switzerland.
Responsibilities
  • Assist in the development of a cross-functional labeling strategy for products worldwide.
  • Support with developing draft labeling text to support marketing applications and labeling update of approved package inserts.
  • Support implementation of a labeling review and approval process.
  • Ensure labeling strategy is aligned with overall regulatory and program strategy.
  • Assist or lead cross-functional labeling and related forums and meetings.
  • Interact with Regulatory Strategy Lead to ensure timely submission and implementation of global labeling requirements.
  • Maintain expertise regarding key labeling requirements worldwide and stay current with labeling guidelines and regulations.
  • Drive the development, implementation, and maintenance of policies and procedures for the creation and management of labeling.
  • Manage the review, QC, and approval process for all product labeling components and CCDS.
  • Support the development of labeling negotiations strategic plans.
  • Train and mentor other RA Labeling colleagues or cross-functional team members in various matters relating to RA labeling.

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals is dedicated to enhancing lives through groundbreaking therapies for neurological and mental health disorders, including Parkinson’s disease psychosis, Rett syndrome, and schizophrenia. This focus on specific, underserved symptoms such as hallucinations and delusions establishes a distinct competitive edge in the pharmaceutical industry. Employees engage in pivotal, enriching work that not only advances medical science but also directly impacts patient well-being, making it a commendable workplace.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

San Diego, California

Founded

1993

Growth & Insights
Headcount

6 month growth

7%

1 year growth

22%

2 year growth

20%
INACTIVE